TMC Life Sciences Berhad Income Statement

Financials in millions MYR. Fiscal year is July - June.

Millions MYR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	364.05	345.54	346.42	311.44	243.77	201.02
Other Revenue	0.1	0.1	-	0.11	-	-
Revenue	364.14	345.63	346.42	311.56	243.77	201.02
Revenue Growth (YoY)	8.39%	-0.23%	11.19%	27.81%	21.27%	9.20%
Cost of Revenue	246.88	235.97	208.4	185.5	155.89	131.52
Gross Profit	117.26	109.67	138.02	126.06	87.88	69.5
Other Operating Expenses	66.42	63.36	52.75	53	39.94	30.65
Operating Expenses	102.65	97.46	80.66	79.01	55.79	43.67
Operating Income	14.61	12.21	57.36	47.05	32.09	25.84
Interest Expense	-8.96	-9.32	-10.25	-9.4	-2.09	-0.44
Interest & Investment Income	3.51	4.17	5.47	3.25	2	2.19
EBT Excluding Unusual Items	9.17	7.06	52.58	40.89	32	27.58
Gain (Loss) on Sale of Assets	0.01	0.01	-	-	-	0.06
Other Unusual Items	0	0	0.04	-	0.18	0.03
Pretax Income	9.18	7.07	52.62	40.89	32.18	27.67
Income Tax Expense	4.1	3.47	11.97	1.63	-9.21	7.42
Net Income	5.08	3.61	40.65	39.26	41.39	20.25
Net Income to Common	5.08	3.61	40.65	39.26	41.39	20.25
Net Income Growth	-82.13%	-91.13%	3.54%	-5.15%	104.35%	27.14%
Shares Outstanding (Basic)	1,742	1,742	1,742	1,742	1,742	1,742
Shares Outstanding (Diluted)	1,742	1,742	1,742	1,742	1,742	1,742
EPS (Basic)	0.00	0.00	0.02	0.02	0.02	0.01
EPS (Diluted)	0.00	0.00	0.02	0.02	0.02	0.01
EPS Growth	-82.12%	-91.13%	3.71%	-5.31%	104.85%	27.18%
Free Cash Flow	3.92	-18.2	49.41	22.61	-32.04	-80.18
Free Cash Flow Per Share	0.00	-0.01	0.03	0.01	-0.02	-0.05
Dividend Per Share	0.002	0.002	0.005	0.004	0.003	0.002
Dividend Growth	-61.96%	-61.96%	16.65%	51.97%	24.74%	9.98%
Gross Margin	32.20%	31.73%	39.84%	40.46%	36.05%	34.57%
Operating Margin	4.01%	3.53%	16.56%	15.10%	13.16%	12.85%
Profit Margin	1.40%	1.04%	11.73%	12.60%	16.98%	10.08%
Free Cash Flow Margin	1.08%	-5.27%	14.26%	7.26%	-13.15%	-39.89%
EBITDA	41.36	37.81	80.28	68.43	44.62	36.02
EBITDA Margin	11.36%	10.94%	23.17%	21.96%	18.30%	17.92%
D&A For EBITDA	26.74	25.6	22.92	21.38	12.54	10.19
EBIT	14.61	12.21	57.36	47.05	32.09	25.84
EBIT Margin	4.01%	3.53%	16.56%	15.10%	13.16%	12.85%
Effective Tax Rate	44.63%	49.01%	22.75%	3.99%	-	26.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.